Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

ClinicalTrials.gov ID: NCT00895011

Public ClinicalTrials.gov record NCT00895011. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

Study identification

NCT ID
NCT00895011
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
VIVUS LLC
Industry
Enrollment
298 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2009 (Type not available)
Primary completion
Apr 2011 (Actual)
Completion
Apr 2011 (Actual)
Last update posted
Oct 1, 2012

2009 – 2011

United States locations

U.S. sites
51
U.S. states
20
U.S. cities
45
Facility City State ZIP Site status
Research Site Phoenix Arizona 85050 —
Research Site Laguna Hills California 92653 —
Research Site Los Angeles California 90073 —
Research Site Los Angeles California 90095 —
Research Site Sacramento California 95817 —
Research Site Aurora Colorado 80045 —
Research Site Englewood Colorado 80113 —
Research Site Parker Colorado 80134 —
Research Site Washington D.C. District of Columbia 20006 —
Research Site Jacksonville Florida 32224 —
Research Site Miami Florida 33136 —
Research Site Trinity Florida 34655 —
Research Site Chicago Illinois 60611 —
Research Site Chicago Illinois 60637 —
Research Site Springfield Illinois 62703 —
Research Site Indianapolis Indiana 46202 —
Research Site New Orleans Louisiana 70112 —
Research Site Shreveport Louisiana 71106 —
Research Site Baltimore Maryland 21287 —
Research Site Towson Maryland 21204 —
Research Site Brighton Massachusetts 02135 —
Research Site Burlington Massachusetts 01805 —
Research Site Jamaica Plain Massachusetts 02130 —
Research Site Ann Arbor Michigan 48109 —
Research Site Hackensack New Jersey 07601 —
Research Site Lawrenceville New Jersey 08648 —
Research Site Brooklyn New York 11215 —
Research Site Brooklyn New York 11235 —
Research Site Garden City New York 11530 —
Research Site Great Neck New York 11021 —
Research Site New York New York 10016 —
Research Site New York New York 10029 —
Research Site New York New York 10065 —
Research Site Poughkeepsie New York 12601 —
Research Site Durham North Carolina 27710 —
Research Site Greensboro North Carolina 27403 —
Research Site Cincinnati Ohio 45212 —
Research Site Cleveland Ohio 44195 —
Research Site Bala-Cynwyd Pennsylvania 19004 —
Research Site Philadelphia Pennsylvania 19107 —
Research Site Philadelphia Pennsylvania 19111 —
Research Site Myrtle Beach South Carolina 29572 —
Research Site Rock Hill South Carolina 29732 —
Research Site Nashville Tennessee 37232 —
Research Site Arlington Texas 76017 —
Research Site Houston Texas 77030 —
Research Site San Antonio Texas 78229 —
Research Site Temple Texas 76508 —
Research Site Charlottesville Virginia 22908 —
Research Site Fairfax Virginia 22030 —
Research Site Richmond Virginia 23235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00895011, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00895011 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →